OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pulmonary fibrosis secondary to COVID-19: a narrative review
Suzana Érico Tanni, Alexandre Todorovic Fabro, André Luís Pereira de Albuquerque, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 6, pp. 791-803
Closed Access | Times Cited: 131
Suzana Érico Tanni, Alexandre Todorovic Fabro, André Luís Pereira de Albuquerque, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 6, pp. 791-803
Closed Access | Times Cited: 131
Showing 1-25 of 131 citing articles:
Pathophysiology and mechanism of long COVID: a comprehensive review
Diego Castanares‐Zapatero, Patrice Chalon, Laurence Kohn, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1473-1487
Open Access | Times Cited: 444
Diego Castanares‐Zapatero, Patrice Chalon, Laurence Kohn, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1473-1487
Open Access | Times Cited: 444
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 151
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 151
Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
Sy Duong‐Quy, Thu Vo-Pham-Minh, Quynh Tran-Xuan, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 295-307
Open Access | Times Cited: 46
Sy Duong‐Quy, Thu Vo-Pham-Minh, Quynh Tran-Xuan, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 295-307
Open Access | Times Cited: 46
Hamster models of COVID-19 pneumonia reviewed: How human can they be?
Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, et al.
Veterinary Pathology (2021) Vol. 59, Iss. 4, pp. 528-545
Open Access | Times Cited: 67
Achim D. Gruber, Theresa C. Firsching, Jakob Trimpert, et al.
Veterinary Pathology (2021) Vol. 59, Iss. 4, pp. 528-545
Open Access | Times Cited: 67
Long COVID-19 Pathophysiology: What Do We Know So Far?
Nikolaos Tziolos, Πέτρος Ιωάννου, Stella Baliou, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 32
Nikolaos Tziolos, Πέτρος Ιωάννου, Stella Baliou, et al.
Microorganisms (2023) Vol. 11, Iss. 10, pp. 2458-2458
Open Access | Times Cited: 32
Research progress of post-acute sequelae after SARS-CoV-2 infection
Taiwei Jiao, Yu‐Ling Huang, Haiyan Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 9
Taiwei Jiao, Yu‐Ling Huang, Haiyan Sun, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 9
From Acute Infection to Prolonged Health Consequences: Understanding Health Disparities and Economic Implications in Long COVID Worldwide
Jaleel Jerry G. Sweis, Fatima Alnaimat, Valeria Flórez Esparza, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 3, pp. 325-325
Open Access | Times Cited: 8
Jaleel Jerry G. Sweis, Fatima Alnaimat, Valeria Flórez Esparza, et al.
International Journal of Environmental Research and Public Health (2024) Vol. 21, Iss. 3, pp. 325-325
Open Access | Times Cited: 8
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 7
Mihai Lazăr, Mihai Săndulescu, Ecaterina Constanța Barbu, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 639-639
Open Access | Times Cited: 7
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives
Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210206-210206
Open Access | Times Cited: 29
Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, et al.
European Respiratory Review (2022) Vol. 31, Iss. 164, pp. 210206-210206
Open Access | Times Cited: 29
Long-term respiratory follow-up of ICU hospitalized COVID-19 patients: Prospective cohort study
Carlos Roberto Ribeiro de Carvalho, Celina Almeida Lamas, Rodrigo Caruso Chate, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280567-e0280567
Open Access | Times Cited: 16
Carlos Roberto Ribeiro de Carvalho, Celina Almeida Lamas, Rodrigo Caruso Chate, et al.
PLoS ONE (2023) Vol. 18, Iss. 1, pp. e0280567-e0280567
Open Access | Times Cited: 16
Current landscape of long COVID clinical trials
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 5
Manojit Bhattacharya, Srijan Chatterjee, Sanskriti Saxena, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111930-111930
Closed Access | Times Cited: 5
The Relationship Between Differential Expression of Non-coding RNAs (TP53TG1, LINC00342, MALAT1, DNM3OS, miR-126-3p, miR-200a-3p, miR-18a-5p) and Protein-Coding Genes (PTEN, FOXO3) and Risk of Idiopathic Pulmonary Fibrosis
G. F. Korytina, V.A. Markelov, Irshat A. Gibadullin, et al.
Biochemical Genetics (2025)
Closed Access
G. F. Korytina, V.A. Markelov, Irshat A. Gibadullin, et al.
Biochemical Genetics (2025)
Closed Access
Role of CCL2/CCR2 Axis in Pulmonary Fibrosis Induced by Respiratory Viruses
S Li, Mingming Pan, Hui Zhao, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
S Li, Mingming Pan, Hui Zhao, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Cluster analysis of post-COVID-19 physical and mental health outcomes 3–6 months after SARS-CoV-2 infection: results of the French Prospective ALCOVID Cohort Study
Thomas Escoda, L. Chiche, H. Faralli, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e089136-e089136
Open Access
Thomas Escoda, L. Chiche, H. Faralli, et al.
BMJ Open (2025) Vol. 15, Iss. 2, pp. e089136-e089136
Open Access
Traditional Herbal Plants and their Phytoconstituents Based Remedies for Respiratory Diseases: A Review
Lauren Campbell
The Open Respiratory Medicine Journal (2025) Vol. 19, Iss. 1
Open Access
Lauren Campbell
The Open Respiratory Medicine Journal (2025) Vol. 19, Iss. 1
Open Access
Global research landscape on nanotechnology in acute lung injury: a bibliometric analysis
Jian Zhang, Shasha Jiang, Jipeng Jiang, et al.
Frontiers in Digital Health (2025) Vol. 7
Open Access
Jian Zhang, Shasha Jiang, Jipeng Jiang, et al.
Frontiers in Digital Health (2025) Vol. 7
Open Access
The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors
Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 60, Iss. 3, pp. 307-316
Open Access | Times Cited: 35
Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 60, Iss. 3, pp. 307-316
Open Access | Times Cited: 35
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation
Christian Rolfo, Noy Meshulami, Alessandro Russo, et al.
Journal of Thoracic Oncology (2021) Vol. 17, Iss. 2, pp. 214-227
Open Access | Times Cited: 34
Christian Rolfo, Noy Meshulami, Alessandro Russo, et al.
Journal of Thoracic Oncology (2021) Vol. 17, Iss. 2, pp. 214-227
Open Access | Times Cited: 34
Niclosamide-loaded nanoparticles (Ncl-NPs) reverse pulmonary fibrosis in vivo and in vitro
Cailing Gan, Yan Wang, Zhongzheng Xiang, et al.
Journal of Advanced Research (2022) Vol. 51, pp. 109-120
Open Access | Times Cited: 25
Cailing Gan, Yan Wang, Zhongzheng Xiang, et al.
Journal of Advanced Research (2022) Vol. 51, pp. 109-120
Open Access | Times Cited: 25
Cellular and Molecular Mechanism of Pulmonary Fibrosis Post-COVID-19: Focus on Galectin-1, -3, -8, -9
Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8210-8210
Open Access | Times Cited: 22
Daniela Adriana Oatis, Erika Simon-Repolski, Cornel Baltă, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8210-8210
Open Access | Times Cited: 22
Olfactory mucosa mesenchymal stem cells alleviate pulmonary fibrosis via the immunomodulation and reduction of inflammation
Ran Duan, Chun‐Gu Hong, Xin Wang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Ran Duan, Chun‐Gu Hong, Xin Wang, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Favipiravir ameliorates bleomycin-induced pulmonary fibrosis by reprogramming M1/M2 macrophage polarization
Ruiqin Zhang, Qiuyan Jiang, Shaoyan Gao, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111774-111774
Closed Access | Times Cited: 4
Ruiqin Zhang, Qiuyan Jiang, Shaoyan Gao, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111774-111774
Closed Access | Times Cited: 4
Post-COVID-19 respiratory sequelae two years after hospitalization: an ambidirectional study
Carlos Roberto Ribeiro de Carvalho, Celina de Almeida Lamas, Luis Augusto Visani de Luna, et al.
The Lancet Regional Health - Americas (2024) Vol. 33, pp. 100733-100733
Open Access | Times Cited: 4
Carlos Roberto Ribeiro de Carvalho, Celina de Almeida Lamas, Luis Augusto Visani de Luna, et al.
The Lancet Regional Health - Americas (2024) Vol. 33, pp. 100733-100733
Open Access | Times Cited: 4
Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1167-1182
Open Access | Times Cited: 11
Nikitha Naomi Dsouza, Varun Alampady, Krishnaprasad Baby, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 3, pp. 1167-1182
Open Access | Times Cited: 11
Pharmacological approaches to pulmonary fibrosis following COVID-19
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
